Sunshine Biopharma (SBFM) Net Cash Flow (QoQ) (2011 - 2026)
Sunshine Biopharma (SBFM) Net Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Sunshine Biopharma | 1.60 Mn | -12.15 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 416.14% |
| Mar 31, 2026 | -131.13% |
| Dec 31, 2025 | -22.21% |
| Sep 30, 2025 | -141.76% |
| Jun 30, 2025 | 218.90% |
| Mar 31, 2025 | 17.67% |
| Dec 31, 2024 | -2,468.87% |
| Sep 30, 2024 | 98.57% |
| Jun 30, 2024 | -433.40% |
| Mar 31, 2024 | 151.66% |
| Dec 31, 2023 | -495.51% |
| Sep 30, 2023 | -2,554.15% |
| Jun 30, 2023 | 100.81% |
| Mar 31, 2023 | 86.63% |
| Dec 31, 2022 | -1,587.43% |
| Sep 30, 2022 | -103.94% |
| Jun 30, 2022 | 156.43% |
| Mar 31, 2022 | 3,415.73% |
| Dec 31, 2021 | -149.75% |
| Sep 30, 2021 | 1,089.51% |